Where undenatured type II collagen is permitted, and what the file must show
In the EU, the US and the UK, undenatured type II collagen is sold as a food ingredient for use in food supplements, not as a medicine. The permission question is usually settled by the ingredient's history and the supplier's file; the harder questions are the source, the native content, the contaminants and the label. This page describes the file as of this review, not legal advice.
Undenatured type II collagen is sold as a food ingredient in the EU, the US and the UK; the file has to prove the source, the native content, the contaminants and the label wording.
The framework in one view
All three markets regulate the finished product, not the drum, and hold the brand responsible for it. The supplier's file supports the ingredient and the statements made about it: what it is, where it comes from, what it measures and what it does not contain. A certificate alone is not that file.
The ingredient is a food of animal origin, so the site has to meet the hygiene rules for that category, and the buyer has to name the species and the tissue. Collagen has a long history of food use, which is why it is not a new material in any of the three markets. A specific preparation or a new process can still raise a market-entry question, answered per product rather than per ingredient family.
European Union
Food supplements are governed by Directive 2002/46/EC and by the national rules that implement it. Some Member States require a notification before a supplement is placed on the market, and the notification is the brand's step, not the supplier's. The labelling rules come from Regulation (EU) No 1169/2011: the ingredient list, the quantitative ingredient declaration where the ingredient is named, the allergen declaration, the nutrition declaration, the lot mark and the storage condition.
Collagen has a history of use in food before 15 May 1997, the reference date in the novel food Regulation (EU) 2015/2283. That history is why a conventional collagen ingredient is not a novel food. A new extraction process, source or preparation that has not been eaten to a significant degree can still need a case-by-case assessment, so ask for a written novel food status statement for the exact product. Contaminants fall under Regulation (EU) 2023/915 and claims under Regulation (EC) No 1924/2006.
Chicken is not on the Annex II allergen list, so no mandatory allergen declaration follows from that list. The word "chicken" still has to appear as the source. The EU regulatory note covers the instruments, and the Annex II entry explains the allergen list.
United States
Under DSHEA, a dietary supplement may contain a dietary ingredient marketed before 15 October 1994, or one with a new dietary ingredient notification accepted by the FDA. The supplier should state which route applies; a brand that assumes the pre-1994 route without a written statement carries an unnecessary risk. The finished product is made under 21 CFR 111 and labelled under 21 CFR 101, including the Supplement Facts panel and the allergen declaration.
Chicken is not one of the major food allergens in the US, so it does not trigger the major-allergen declaration on its own. The ingredient statement still names it. Structure/function statements are permitted if they are truthful, not misleading and notified to the FDA within 30 days of marketing; a statement that a product diagnoses or addresses a disease is a drug claim and is not permitted for a supplement.
Importers also need the facility registration and the prior notice that apply to the shipment. Those are logistics steps, but they are part of the same file. The US regulatory note sets out the instruments.
Contaminant limits
| Parameter | Catalogue limit | EU supplement limit | Note |
|---|---|---|---|
| Lead | ≤3 mg/kg | 3.0 mg/kg | At the limit, no margin |
| Cadmium | ≤1 mg/kg | 1.0 mg/kg | At the limit, no margin |
| Mercury | ≤0.1 mg/kg | 0.10 mg/kg | At the limit, no margin |
| Arsenic | ≤2 mg/kg | No general maximum | Customer limit |
| APC | ≤1,000 cfu/g | No harmonised limit | Buyer's specification |
| Yeast and mould | ≤100 cfu/g | No harmonised limit | Buyer's specification |
| E. coli | Absent | No harmonised limit | Buyer's specification |
| Salmonella | Absent | No harmonised limit | Buyer's specification |
The catalogue lead, cadmium and mercury limits sit exactly at the EU food-supplement maximum, so a compliant lot has no analytical margin. A brand that wants margin should set an internal limit below the regulation and ask for the result against it. The arsenic and microbiological lines are contractual, because the EU has no general harmonised maximum for them in supplements. The UK applies its own retained limits in Great Britain, largely aligned with these figures, and the EU regulation in Northern Ireland; check the current text.
What the label can say
There is no authorised EU health claim for type II collagen, so an EU label cannot attach a health benefit to the ingredient. "Native" and "undenatured" describe the specification and process, not a health effect, and they need the ELISA method and result. "Type II" is an identity statement and needs the type II assay. "10%" is the native content of the powder, not the weight in the capsule.
In the US, a structure/function statement is possible within the DSHEA rules, with its notification and substantiation. In both markets a disease-related claim is out of scope for a supplement. The supplier's file supports the ingredient facts; the brand decides the claim and keeps the evidence. No page on this site makes a disease-related claim.
The document pack
| Document | What it proves |
|---|---|
| Certificate of analysis | Lot values against the specification, with methods |
| Specification | The agreed ranges, including the grade target |
| TDS and SDS | Handling, solubility, storage and safety |
| ELISA method sheet | Antibody, standard and extraction behind the native result |
| Source and origin statement | Species, tissue, country of origin, animal-origin status |
| Allergen statement | Chicken declaration and cross-contact controls |
| Contaminant and micro reports | The results behind the limits table |
| Market status statement | Novel food position (EU) and NDI route (US) |
| Stability summary | The shelf life and the pack it was tested in |
Release checklist
- The ingredient name on the label matches the specification and the COA.
- The source and tissue are named as chicken sternum.
- The native content is declared and supported by the ELISA method and result.
- The protein factor and the basis are stated on the certificate.
- The contaminant results are compared with the destination limits, not only with the catalogue.
- The allergen and animal-origin statements are on file and match the label.
- The EU novel food and US NDI positions are confirmed in writing for this product.
- The claims have been reviewed against the permitted list for each market.
- The lot number on the COA, the pack and the retained sample is the same.
For the native result itself, see the identity page; for the parameters, see the COA page; for the ordering documents, see the MOQ page. The full range is on the product page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation